arBtrage CAPITALIZING MARKETS — checking… Sign in Sign up
Calendar /

ProQR Therapeutics N.V.

PRQR Health Care Biotechnology: Pharmaceutical Preparations
$1.29
▼ -5.8% Today
as of Oct 23, 16:51 ET
Last 30 days -30.65% Sep 14 → Oct 23
$1.24 $1.42 $1.59 $1.77 $1.95 Sep 14 Sep 22 Sep 30 Oct 07 Oct 15 Oct 23
Open
$1.33
High
$1.33
Low
$1.24
Volume
$2M
Avg Vol
$702,179
Mkt Cap
$230M
P/E (TTM)
—
Beta
—
52w High
$3.00
52w Low
$1.24
Div Yield
—
Shares Out
—

Recent Press Releases & News last 60 days · 5 items

Oct 2 · 08:02 MarketBeat
ProQR Reports First Human Validation of RNA Editing Platform in Liver Disease
Sep 23 · 12:00 PR GlobeNewswire
ProQR Announces Appointment of Chris Hart as Chief Data and AI Officer and Thomas Wolf to join the Board of Directors as Strategic AI Advisor
Sep 9 · 13:23 MT Newswires
ProQR Therapeutics Doses First Participant in Phase 1 Trial of Liver Disease Treatment
▸ Show all 5 press releases & news Free account →

PRQR earnings at a glance

ProQR Therapeutics N.V. (PRQR) is scheduled to report earnings on Thursday, November 5, 2026 — in 13 days. Analysts expect earnings per share of -$0.11, compared with -$0.12 in the same quarter last year (+8%). The options market is pricing a move of about ±69.7% after the report, a range of roughly $0.39 to $2.19 from today's $1.29. Over its last 2 reports the stock rose the next day 0 times and fell 2, moving ±0.9% on average; after the most recent report on May 12, 2026 it moved -0.6%. That means options currently expect more movement than PRQR has typically delivered. PRQR beat the consensus EPS estimate in 0 of its last 4 reported quarters. Implied volatility is currently 364%. The share price of $1.29 sits near its 52-week low.

More Health Care stocks · All stocks · Earnings calendar

Overview

52-week range
$1.24
$3.00
3% of range
Avg surprise (last 4)
-29.3%
Avg reaction (last 2)
-0.9%
0% positive
Latest IV / EM
364%
EM ±69.7% · $2 · Oct 16

Earnings trends

EPS — actual vs estimate Actual Estimate
$-0.65$-0.38$-0.11$0.15$0.42 Actual $-0.11Est $-0.09Actual $-0.14Est $-0.08Actual $-0.12Est $-0.10Actual $-0.15Est $-0.15 Mar/2025Jun/2025Sep/2025Mar/2026

Earnings history

DatePeriodActual EPSEstSurpriseYoY %ΔDay reactSource
Tue May 12, 2026Mar/2026 $-0.15 $-0.15 0.0% -36.4% -0.6% earnings
Thu Nov 6, 2025Sep/2025 $-0.12 $-0.10 -20.0% — — earnings
Thu Aug 7, 2025Jun/2025 $-0.14 $-0.08 -75.0% — — earnings
Thu May 8, 2025Mar/2025 $-0.11 $-0.09 -22.2% — -1.3% earnings

Upcoming

DateFiscalTimeEPS EstLY EPSYoY %Δ
Thu Nov 5, 2026Sep/2026OTHER -$0.11-$0.12 +8.3%

Implied volatility — last 90 days

45%806%1567%2329%3090% Jun 08 — IV 1980% · EM ±261.4%Jun 09 — IV 2100% · EM ±263.2%Jun 19 — IV 910% · EM ±201.1%Jun 22 — IV 1012% · EM ±211.4%Jun 23 — IV 537% · EM ±109.8%Jun 24 — IV 1048% · EM ±209.9%Jun 25 — IV 1381% · EM ±270.4%Jun 26 — IV 598% · EM ±114.4%Jun 29 — IV 308% · EM ±54.6%Jun 30 — IV 1168% · EM ±201.1%Jul 01 — IV 582% · EM ±97.1%Jul 02 — IV 1332% · EM ±215.5%Jul 03 — IV 1379% · EM ±215.5%Jul 06 — IV 1586% · EM ±219.7%Jul 07 — IV 1779% · EM ±234.9%Jul 08 — IV 1900% · EM ±238.1%Jul 09 — IV 1876% · EM ±221.6%Jul 10 — IV 915% · EM ±101.2%Jul 13 — IV 1162% · EM ±97.1%Jul 14 — IV 3090% · EM ±223.5%Jul 21 — IV 46% · EM ±10.6%Jul 24 — IV 1302% · EM ±287.8%Jul 28 — IV 387% · EM ±79.1%Jul 30 — IV 100% · EM ±19.6%Jul 31 — IV 1580% · EM ±302.3%Aug 04 — IV 889% · EM ±153.1%Aug 05 — IV 46% · EM ±7.6%Aug 10 — IV 578% · EM ±80.1%Aug 11 — IV 493% · EM ±65.1%Aug 14 — IV 1626% · EM ±179.7%Aug 17 — IV 95% · EM ±7.9%Aug 18 — IV 109% · EM ±7.9%Aug 24 — IV 148% · EM ±30.9%Aug 25 — IV 395% · EM ±80.9%Aug 26 — IV 234% · EM ±46.8%Aug 27 — IV 396% · EM ±77.6%Aug 31 — IV 238% · EM ±42.3%Sep 01 — IV 253% · EM ±43.6%Sep 02 — IV 216% · EM ±36.0%Sep 03 — IV 297% · EM ±48.1%Sep 21 — IV 77% · EM ±16.1%Sep 22 — IV 77% · EM ±15.8%Sep 23 — IV 79% · EM ±15.8%Sep 25 — IV 364% · EM ±69.7%

Sector peers

SIGA
SIGA Technologies Inc.
$234M $3.120.0%
SLGL
Sol-Gel Technologies Ltd.
$238M $69.45+5.7%
KROS
Keros Therapeutics, Inc.
$222M $11.28+0.9%
NATR
Nature's Sunshine Products, Inc.
$222M $12.15-0.9%
AKBA
Akebia Therapeutics, Inc.
$241M $0.57-3.1%
SION
Sionna Therapeutics, Inc.
$218M $3.60-7.0%

PRQR earnings FAQ

When is PRQR's next earnings date?

ProQR Therapeutics N.V. is expected to report on November 5, 2026.

What is PRQR's expected move for earnings?

Options currently price a move of about ±69.7%, or $0.90 per share either way from $1.29.

How does PRQR stock usually react to earnings?

Across the last 2 reports the average next-day move was ±0.9%, up 0 times and down 2 times.

What EPS are analysts expecting from ProQR Therapeutics N.V.?

The consensus estimate is -$0.11 per share, versus -$0.12 a year ago.

What is PRQR's implied volatility?

PRQR's at-the-money implied volatility is about 364% based on the latest options snapshot.

View on Nasdaq ↗
🔒 Preview mode. Create a free account to unlock the full earnings calendar, all panels, heatmaps, options flow, and screener.
Sign up free → Sign in